These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12229110)

  • 1. [Antipsychotic agents and weight gain].
    Raaska K
    Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction. Weight gain with psychotropics: size does matter.
    Masand PS
    J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
    Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
    Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.
    Dwyer DS; Donohoe D; Lu XH; Aamodt EJ
    Int Rev Neurobiol; 2005; 65():211-47. PubMed ID: 16140058
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
    Koponen H; Saari K; Savolainen M; Isohanni M
    Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of an antipsychotic.
    Med Lett Drugs Ther; 2003 Dec; 45(1172):102-4. PubMed ID: 14679353
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
    Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
    Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer strategies for coping with antipsychotic medication side effects.
    Meehan T; Stedman T; Wallace J
    Australas Psychiatry; 2011 Feb; 19(1):74-7. PubMed ID: 21303281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
    Hrdlicka M; Zedkova I; Blatny M; Urbanek T
    Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between weight and medications in psychological illnesses of children.
    Apter A; Steingart L
    World Rev Nutr Diet; 2013; 106():174-80. PubMed ID: 23428698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of therapeutic efficacy versus sedation with antipsychotic agents.
    J Clin Psychiatry; 1996 Jun; 57(6):1-12. PubMed ID: 8666557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atypical antipsychotic-induced weight gain].
    Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight and adherence to treatment in psychotic disorders.
    Kemp RA; David AS
    Br J Hosp Med; 1995 Sep 6-19; 54(5):222-7. PubMed ID: 8528530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
    Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
    Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an anti-fat bias among schizophrenia patients?
    Pierson KE
    Obesity (Silver Spring); 2006 Dec; 14(12):2305. PubMed ID: 17189559
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is antipsychotic drug therapy predictable?].
    Leinonen E; Anttila S; Kampman O; Illi A
    Duodecim; 2005; 121(1):45-52. PubMed ID: 15712835
    [No Abstract]   [Full Text] [Related]  

  • 18. The 'boon and bane' of antipsychotic-induced metabolic syndrome.
    Venkatasubramanian G
    Acta Psychiatr Scand; 2009 Dec; 120(6):500-1; author reply 501. PubMed ID: 19489746
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaining: pediatric patients and use of atypical antipsychotics.
    Towbin KE
    Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.